Literature DB >> 3423206

Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.

J J Keating1, C J O'Brien, A J Stellon, B C Portmann, R D Johnson, P J Johnson, R Williams.   

Abstract

To determine which clinical and laboratory features may influence survival in patients with chronic active hepatitis, we undertook a retrospective study of 204 patients seen on this unit over a 15-year period and applied logistic regression analysis. One hundred and six patients had autoimmune chronic active hepatitis, 69 'cryptogenic' chronic active hepatitis (no autoimmune markers or other aetiological factors identified), and 29 were HBsAg-seropositive. Variceal haemorrhage, encephalopathy and ascites were common presenting features in the cryptogenic group while the presence of jaundice and other immunopathic diseases did not differ between the groups. Cirrhosis was more common at presentation in the cryptogenic group. Remission was induced with corticosteroids and azathioprine in 82 per cent of patients with autoimmune chronic active hepatis and in 77 per cent of patients with cryptogenic chronic active hepatitis and the annual relapse rate was similar in the autoimmune and cryptogenic groups. Five-year survival was 87 per cent in the autoimmune group, 65 per cent in the cryptogenic group, and 80 per cent in those with HBsAg-positive disease, and on logistic regression analysis, the presence of cirrhosis at presentation was the only independent factor which adversely affected survival. Overall survival in the cirrhotic patients at five and 12 years was 63 and 48 per cent respectively compared with 95 and 92 per cent in those without cirrhosis.

Entities:  

Mesh:

Year:  1987        PMID: 3423206

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  7 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 2.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Treatment of autoimmune hepatitis.

Authors:  P J Johnson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 4.  Infectious complications of liver disease.

Authors:  P D King
Journal:  J Gen Intern Med       Date:  1993-06       Impact factor: 5.128

Review 5.  Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.

Authors:  Kathie Béland; Pascal Lapierre; Fernando Alvarez
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

Review 6.  Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.

Authors:  Albert J Czaja
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; H Wright; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; J McMichael; W Irish; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-05       Impact factor: 10.864

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.